MIR9-1HG
gene geneOn this page
Also known as CROC4
Summary
MIR9-1HG (MIR9-1 host gene, HGNC:30780) is a long non-coding RNA gene on chromosome 1q22. May play a role in FOS signaling pathways involved in development and remodeling of neurons.
Involved in positive regulation of transcription by RNA polymerase II. Predicted to be located in nucleus.
Source: NCBI Gene 10485 — RefSeq curated summary.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30780 |
| Approved symbol | MIR9-1HG |
| Name | MIR9-1 host gene |
| Location | 1q22 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | CROC4 |
| Ensembl gene | ENSG00000125462 |
| Ensembl biotype | lncRNA |
| OMIM | 618747 |
| Entrez | 10485 |
| RNAcentral | URS0001BBE48E — lncRNA, 706 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 200 — 200 lncRNA
ENST00000310027, ENST00000357975, ENST00000368242, ENST00000368243, ENST00000400991, ENST00000441085, ENST00000452465, ENST00000462458, ENST00000463309, ENST00000464203, ENST00000464238, ENST00000465270, ENST00000465570, ENST00000469813, ENST00000471156, ENST00000476966, ENST00000482932, ENST00000484428, ENST00000486517, ENST00000488498, ENST00000489877, ENST00000489918, ENST00000492750, ENST00000495000, ENST00000497822, ENST00000497824, ENST00000498346, ENST00000608007, ENST00000656222, ENST00000663987, ENST00000667036, ENST00000673141, ENST00000700991, ENST00000701195, ENST00000701576, ENST00000701766, ENST00000701992, ENST00000702047, ENST00000702128, ENST00000702336, ENST00000702396, ENST00000702513, ENST00000702702, ENST00000702770, ENST00000702884, ENST00000702897, ENST00000702912, ENST00000702915, ENST00000702918, ENST00000702928, ENST00000702936, ENST00000702937, ENST00000702952, ENST00000702953, ENST00000702966, ENST00000702968, ENST00000702969, ENST00000702972, ENST00000702975, ENST00000702978, ENST00000702990, ENST00000702998, ENST00000702999, ENST00000703000, ENST00000703018, ENST00000703026, ENST00000703029, ENST00000703031, ENST00000703035, ENST00000703043, ENST00000703047, ENST00000703048, ENST00000703052, ENST00000703053, ENST00000703058, ENST00000703062, ENST00000703065, ENST00000703067, ENST00000703069, ENST00000703072, ENST00000703073, ENST00000703078, ENST00000703079, ENST00000703083, ENST00000703084, ENST00000703085, ENST00000703086, ENST00000703088, ENST00000703089, ENST00000703090, ENST00000703092, ENST00000703093, ENST00000703094, ENST00000703095, ENST00000703098, ENST00000758273, ENST00000758274, ENST00000758275, ENST00000758276, ENST00000758277, ENST00000758278, ENST00000758279, ENST00000758280, ENST00000758281, ENST00000758282, ENST00000758283, ENST00000758284, ENST00000758285, ENST00000758286, ENST00000758287, ENST00000758288, ENST00000758289, ENST00000758290, ENST00000758291, ENST00000758292, ENST00000758293, ENST00000758294, ENST00000758295, ENST00000758296, ENST00000758297, ENST00000758298, ENST00000758299, ENST00000758300, ENST00000758301, ENST00000758302, ENST00000758303, ENST00000758304, ENST00000758305, ENST00000758306, ENST00000758307, ENST00000758308, ENST00000758309, ENST00000758310, ENST00000758311, ENST00000758312, ENST00000758313, ENST00000758314, ENST00000758315, ENST00000758316, ENST00000758317, ENST00000758318, ENST00000758319, ENST00000758320, ENST00000758321, ENST00000758322, ENST00000758323, ENST00000758324, ENST00000758325, ENST00000758326, ENST00000758327, ENST00000758328, ENST00000758329, ENST00000758330, ENST00000758331, ENST00000758332, ENST00000758333, ENST00000758334, ENST00000758335, ENST00000758336, ENST00000758337, ENST00000758338, ENST00000758339, ENST00000758340, ENST00000758341, ENST00000758342, ENST00000758343, ENST00000758344, ENST00000758345, ENST00000758346, ENST00000758347, ENST00000758348, ENST00000758349, ENST00000758350, ENST00000758351, ENST00000758352, ENST00000758353, ENST00000758354, ENST00000758355, ENST00000758356, ENST00000758357, ENST00000758358, ENST00000758359, ENST00000758360, ENST00000758361, ENST00000758362, ENST00000758363, ENST00000758364, ENST00000758365, ENST00000758366, ENST00000758367, ENST00000758368, ENST00000758369, ENST00000758370, ENST00000758371, ENST00000792507, ENST00000792508, ENST00000792509, ENST00000792510, ENST00000792511, ENST00000792512
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000310027 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001946068 | 156404250 | 156404601 |
| ENSE00003543775 | 156407842 | 156407975 |
| ENSE00003598939 | 156414654 | 156414753 |
| ENSE00003607413 | 156426798 | 156426872 |
| ENSE00004110133 | 156429376 | 156429631 |
Expression profiles
Bgee: expression breadth ubiquitous, 208 present calls, max score 99.92.
FANTOM5 (CAGE): breadth broad, TPM avg 25.5070 / max 857.5192, expressed in 552 samples.
FANTOM5 promoters (13 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 15120 | 14.8951 | 191 |
| 15118 | 9.3799 | 497 |
| 15111 | 0.2332 | 77 |
| 15121 | 0.2076 | 90 |
| 15114 | 0.1722 | 104 |
| 15116 | 0.1393 | 41 |
| 15117 | 0.1120 | 35 |
| 15112 | 0.0948 | 51 |
| 15107 | 0.0692 | 6 |
| 15113 | 0.0554 | 35 |
Top tissues by expression
290 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ventricular zone | UBERON:0003053 | 99.92 | gold quality |
| ganglionic eminence | UBERON:0004023 | 99.80 | gold quality |
| dorsal motor nucleus of vagus nerve | UBERON:0002870 | 99.70 | gold quality |
| nucleus accumbens | UBERON:0001882 | 99.69 | gold quality |
| right frontal lobe | UBERON:0002810 | 99.68 | gold quality |
| paraflocculus | UBERON:0005351 | 99.65 | gold quality |
| putamen | UBERON:0001874 | 99.63 | gold quality |
| caudate nucleus | UBERON:0001873 | 99.58 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 99.53 | gold quality |
| amygdala | UBERON:0001876 | 99.51 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 99.51 | gold quality |
| hypothalamus | UBERON:0001898 | 99.50 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 99.48 | gold quality |
| inferior olivary complex | UBERON:0002127 | 99.44 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 99.40 | gold quality |
| Ammon’s horn | UBERON:0001954 | 99.39 | gold quality |
| entorhinal cortex | UBERON:0002728 | 99.37 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 99.35 | gold quality |
| temporal lobe | UBERON:0001871 | 99.32 | gold quality |
| cerebellar cortex | UBERON:0002129 | 99.31 | gold quality |
| substantia nigra | UBERON:0002038 | 99.29 | gold quality |
| middle frontal gyrus | UBERON:0002702 | 99.28 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 99.28 | gold quality |
| telencephalon | UBERON:0001893 | 99.26 | gold quality |
| cingulate cortex | UBERON:0003027 | 99.25 | gold quality |
| cerebral cortex | UBERON:0000956 | 99.24 | gold quality |
| cerebellum | UBERON:0002037 | 99.22 | gold quality |
| neocortex | UBERON:0001950 | 99.14 | gold quality |
| cortical plate | UBERON:0005343 | 99.14 | gold quality |
| prefrontal cortex | UBERON:0000451 | 99.12 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-25 | yes | 27.74 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
1 targets.
| Target | Regulation |
|---|---|
| FOS | Activation |
Literature-anchored findings (GeneRIF, showing 2)
- CACNA1G-AS1 promotes hepatocellular carcinoma progression through regulating the miR-2392/C1orf61 pathway. (PMID:30908634)
- C1orf61 promotes hepatocellular carcinoma metastasis and increases the therapeutic response to sorafenib. (PMID:33915231)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.